NOD2 and colon carcinoma: The complete selectivity of GSK669 and GSK400 towards inhibition of NOD2 but not NOD1-mediated IL-8 secretion was also evident in HCT116 colon carcinoma cells which endogenously express both NOD1 and NOD2.